Predictive Oncology Inc.
POAI
$13.89
-$0.38-2.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.07M | 1.13M | 1.03M | 737.50K | 1.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.07M | 1.13M | 1.03M | 737.50K | 1.07M |
| Cost of Revenue | 550.80K | 546.50K | 523.80K | 475.00K | 376.00K |
| Gross Profit | 519.50K | 588.40K | 505.60K | 262.40K | 692.40K |
| SG&A Expenses | 9.90M | 9.78M | 10.99M | 11.65M | 12.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.45M | 10.32M | 11.51M | 12.12M | 12.88M |
| Operating Income | -9.38M | -9.19M | -10.48M | -11.38M | -11.81M |
| Income Before Tax | -8.65M | -9.13M | -10.41M | -11.30M | -11.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.65 | -9.13 | -10.41 | -11.30 | -11.76 |
| Earnings from Discontinued Operations | -1.13M | -1.76M | -2.26M | -2.67M | -2.28M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.78M | -10.89M | -12.66M | -13.97M | -14.04M |
| EBIT | -9.38M | -9.19M | -10.48M | -11.38M | -11.81M |
| EBITDA | -9.24M | -9.04M | -10.34M | -11.24M | -11.54M |
| EPS Basic | -20.67 | -27.49 | -37.94 | -45.89 | -50.41 |
| Normalized Basic EPS | -11.33 | -14.23 | -19.46 | -23.55 | -26.45 |
| EPS Diluted | -20.71 | -27.54 | -38.03 | -45.99 | -50.50 |
| Normalized Diluted EPS | -11.33 | -14.23 | -19.46 | -23.55 | -26.45 |
| Average Basic Shares Outstanding | 1.96M | 1.66M | 1.45M | 1.28M | 1.12M |
| Average Diluted Shares Outstanding | 1.96M | 1.66M | 1.45M | 1.28M | 1.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |